Pamela J. Cramer insider trades: Rhythm Pharmaceuticals (RYTM) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Pamela reports to the SEC
Open-market buys and sales
23 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | RYTM | ↓ Sell | 3,350 | $111.00 | $372K | Direct | Dec 15, 2025 (4d) |
| Nov 20, 2025 | RYTM | ↓ Sell | 3,350 | $105.00 | $352K | Direct | Nov 24, 2025 (4d) |
| Nov 10, 2025 | RYTM | ↓ Sell | 22,866 | $99.00 | $2.3M | Direct | Nov 12, 2025 (2d) |
| Jul 29, 2025 | RYTM | ↓ Sell | 1,520 | $85.93 | $131K | Direct | Jul 29, 2025 (0d) |
| Jul 9, 2025 | RYTM | ↓ Sell | 15,572 | $77.13 | $1.2M | Direct | Jul 11, 2025 (2d) |
| Jun 6, 2025 | RYTM | ↓ Sell | 7,031 | $68.05 | $478K | Direct | Jun 10, 2025 (4d) |
| Apr 29, 2025 | RYTM | ↓ Sell | 7,031 | $65.09 | $458K | Direct | May 1, 2025 (2d) |
| Apr 8, 2025 | RYTM | ↓ Sell | 20,760 | $60.14 | $1.2M | Direct | Apr 10, 2025 (2d) |
| Feb 19, 2025 | RYTM | ↓ Sell | 982 | $57.22 | $56K | Direct | Feb 19, 2025 (0d) |
| Feb 11, 2025 | RYTM | ↓ Sell | 701 | $57.51 | $40K | Direct | Feb 11, 2025 (0d) |
| Feb 4, 2025 | RYTM | ↓ Sell | 902 | $59.43 | $54K | Direct | Feb 4, 2025 (0d) |
| Nov 7, 2024 | RYTM | ↓ Sell | 9,375 | $62.50 | $586K | Direct | Nov 8, 2024 (1d) |
| Sep 9, 2024 | RYTM | ↓ Sell | 4,099 | $50.03 | $205K | Direct | Sep 11, 2024 (2d) |
| Aug 26, 2024 | RYTM | ↓ Sell | 3,200 | $50.01 | $160K | Direct | Aug 28, 2024 (2d) |
| Aug 9, 2024 | RYTM | ↓ Sell | 49,006 | $45.15 | $2.2M | Direct | Aug 13, 2024 (4d) |
| Jul 29, 2024 | RYTM | ↓ Sell | 1,395 | $49.06 | $68K | Direct | Jul 30, 2024 (1d) |
| Mar 19, 2024 | RYTM | ↓ Sell | 15,515 | $39.22 | $608K | Direct | Mar 19, 2024 (0d) |
| Feb 12, 2024 | RYTM | ↓ Sell | 696 | $51.38 | $36K | Direct | Feb 13, 2024 (1d) |
| Feb 1, 2024 | RYTM | ↓ Sell | 946 | $45.06 | $43K | Direct | Feb 5, 2024 (4d) |
| Jul 26, 2023 | RYTM | ↓ Sell | 930 | $17.64 | $16K | Direct | Jul 28, 2023 (2d) |
| Feb 9, 2023 | RYTM | ↓ Sell | 834 | $27.66 | $23K | Direct | Feb 13, 2023 (4d) |
| Aug 19, 2022 | RYTM | ↓ Sell | 13,493 | $24.83 | $335K | Direct | Aug 23, 2022 (4d) |
| Jul 27, 2022 | RYTM | ↓ Sell | 901 | $11.68 | $11K | Direct | Jul 28, 2022 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other RYTM insiders
Open-market trades in the last 12 months
About Pamela J. Cramer's insider trades
Pamela J. Cramer is Chief Human Resources Officer at Rhythm Pharmaceuticals (RYTM). Since Jul 27, 2022, Pamela has reported no open-market purchases and 23 sales worth $11.0M on SEC Form 4. In the last 12 months: 3 sales ($3.0M).
Their filings also include option exercises (23 filings), grants and awards (6 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RYTM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.